Lymphoma classification update: B-cell non-Hodgkin lymphomas (Q38843988)

6 September 2017

title

Lymphoma classification update: B-cell non-Hodgkin lymphomas (English)

1 reference

6 September 2017

Andrew L Feldman

0 references

Manli Jiang

1 reference

6 September 2017

N Nora Bennani

series ordinal

1 reference

6 September 2017

publication date

11 April 2017

1 reference

Expert Review of Hematology

6 September 2017

published in

1 reference

6 September 2017

1 reference

6 September 2017

1 reference

6 September 2017

page(s)

405-415

1 reference

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

The 2016 revision of the World Health Organization classification of lymphoid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

2016 US lymphoid malignancy statistics by World Health Organization subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

B-cell clones as early markers for chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Risk of non-hematologic cancer in individuals with high-count monoclonal B-cell lymphocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

SF3B1 and other novel cancer genes in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

p53 and Notch signaling in chronic lymphocytic leukemia: clues to identifying novel therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

NOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

A chronic lymphoproliferative disorder with distinctive features: a distinct variant of hairy-cell leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

BRAF mutations in hairy-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Regulation of hairy-cell survival through constitutive activation of mitogen-activated protein kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Novel therapeutic options for relapsed hairy cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström's macroglobulinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Oncogenically active MYD88 mutations in human lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Analysis of the coding genome of diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Follicular lymphoma-like B cells of uncertain significance (in situ follicular lymphoma) may infrequently progress, but precedes follicular lymphoma, is associated with other overt lymphomas and mimics follicular lymphoma in flow cytometric studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

t(14;18) Translocation: A Predictive Blood Biomarker for Follicular Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Follicular lymphomas in children and young adults: a comparison of the pediatric variant with usual follicular lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Outcome of deferred initial therapy in mantle-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Time to treatment does not influence overall survival in newly diagnosed mantle-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Molecular pathogenesis of mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Leukemic non-nodal mantle cell lymphomas have a distinct phenotype and are associated with deletion of PARP1 and 13q14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

"In situ-like" mantle cell lymphoma: a report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Con

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Diffuse Large B-cell Lymphomas of Immunoblastic Type Are a Major Reservoir for MYC-IGH Translocations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

MYC alterations in diffuse large B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

High levels of nuclear MYC protein predict the presence of MYC rearrangement in diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Immunohistochemical detection of MYC-driven diffuse large B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Triple Hit Lymphoma: Rare Cases With Less Dire Than Usual Prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Selective inhibition of BET bromodomains

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Translocation of immunoglobulin VH genes in Burkitt lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Interphase fluorescence in situ hybridization for detection of 8q24/MYC breakpoints on routine histologic sections: validation in Burkitt lymphomas from three geographic regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

The genetic landscape of mutations in Burkitt lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Crystal structure of transcription factor E47: E-box recognition by a basic region helix-loop-helix dimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Id proteins: small molecules, mighty regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Post-transplant molecularly defined Burkitt lymphomas are frequently MYC-negative and characterized by the 11q-gain/loss pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

Primary Follicular Lymphoma of the Duodenum Is a Distinct Mucosal/Submucosal Variant of Follicular Lymphoma: A Retrospective Study of 63 Cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474086.2017.1318053

10.1080/17474086.2017.1318053

21 January 2018

Identifiers

DOI

1 reference

6 September 2017

1 reference